EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access

Esaxerenone improves the blood pressure and metabolic parameters of hypertensive subjects with diabetes

Saki Kuwabara, Hiraku Kameda, Kei Yokozeki, Aika Miya, Hiroshi Nomoto, Kyu Yong Cho, Akinobu Nakamura, Naohide Koyanagawa, Kohei Yamamoto, Jun Takeuchi, So Nagai, Arina Miyoshi und 4 weitere

Endocrine Journal · 2025

DOI: 10.1507/endocrj.ej24-0639 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Endocrine Journal, 2025. Verfasst von Saki Kuwabara und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: Hypertension, Diabetes Mellitus, Type 2, Blood Pressure, Antihypertensive Agents. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionDiabetes Mellitus, Type 2Blood PressureAntihypertensive AgentsPyrrolesSulfonesMineralocorticoid Receptor AntagonistsHumansMaleMiddle AgedFemaleRetrospective StudiesAgedAmlodipineGlycated Hemoglobin

Stichwörter der Autor:innen

DiabetesEsaxerenoneHypertensionLiver enzymeObesity

Substanzen

esaxerenoneAntihypertensive AgentsPyrrolesSulfonesMineralocorticoid Receptor AntagonistsAmlodipineGlycated Hemoglobin

Autor:innen und Institutionen

  • Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  • Division of Endocrinology, Metabolism, and Rheumatology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.
  • Shiomidai Clinic, Otaru, Japan.
  • Department of Endocrinology, Metabolism, and Diabetes, National Hospital Organization Hokkaido Medical Center, Sapporo, Japan.
  • Sapporo Diabetes and Thyroid Clinic, Sapporo, Japan.
  • Division of Diabetes and Endocrinology, Department of Medicine, NTT Medical Center Sapporo, Sapporo, Japan.

Zitieren

APA

Kuwabara, S., Kameda, H., Yokozeki, K., Miya, A., Nomoto, H., Cho, K. Y., Nakamura, A., Koyanagawa, N., Yamamoto, K., Takeuchi, J., Nagai, S., Miyoshi, A., Wada, N., Taneda, S., Kurihara, Y., & Atsumi, T. (2025). Esaxerenone improves the blood pressure and metabolic parameters of hypertensive subjects with diabetes. Endocrine Journal. https://doi.org/10.1507/endocrj.ej24-0639

Vancouver

Kuwabara S, Kameda H, Yokozeki K, Miya A, Nomoto H, Cho KY, et al. Esaxerenone improves the blood pressure and metabolic parameters of hypertensive subjects with diabetes. Endocrine Journal. 2025. doi:10.1507/endocrj.ej24-0639

BibTeX
@article{Kuwabara2025,
  author = {Kuwabara, Saki and Kameda, Hiraku and Yokozeki, Kei and Miya, Aika and Nomoto, Hiroshi and Cho, Kyu Yong and Nakamura, Akinobu and Koyanagawa, Naohide and Yamamoto, Kohei and Takeuchi, Jun and Nagai, So and Miyoshi, Arina and Wada, Norio and Taneda, Shinji and Kurihara, Yoshio and Atsumi, Tatsuya},
  title = {Esaxerenone improves the blood pressure and metabolic parameters of hypertensive subjects with diabetes},
  journal = {Endocrine Journal},
  year = {2025},
  doi = {10.1507/endocrj.ej24-0639}
}
Kostenlos starten →